Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); a minor UI element, 'Back to Top', was removed.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific medical conditions related to leukemia have been removed. The revision number has also been updated.SummaryDifference3%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference1.0%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.